parishin C

Known as: 1,3-bis(4-(D-glucopyranosyloxy)benzyl)citrate 
 

Topic mentions per year

Topic mentions per year

2001-2016
01220012016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Gastrodia elata Blume, called Tianma in China, has been widely used to treat headaches, convulsions and epilepsy for thousands of… (More)
Is this relevant?
2017
2017
INTRODUCTION Gastrodia elata tuber (GET) has been widely used in China as a famous herbal medicine. However, the quality control… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
The rhizome of Gastrodia elata (GE), a herb medicine, has been used for treatment of neuronal disorders in Eastern Asia for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
In this study, direct ionization mass spectrometry (DI-MS) for rapid authentication of Gastrodiae rhizoma (known as Tianma in… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
To make clear of the absorbed components of Tianzhusan (TZS) and its possible mechanism in preventing vascular dementia (VD), the… (More)
Is this relevant?
2014
2014
A simple, rapid and sensitive ultra high performance liquid chromatography with fluorescence detection (UHPLC-FLD) method was… (More)
Is this relevant?
2012
2012
Two new compounds (1 and 2), together with twenty-one known compounds (3-23), were isolated by a combination of various… (More)
Is this relevant?
2010
2010
Parishin C, a major component of Gastrodia elata BLUME (GE), was purified from GE. Because GE modulates the serotonergic system… (More)
Is this relevant?
2004
2004
The mass spectra of seven sesquiterpene lactones — leucomisin, austricin, parishin B, parishin C, matricarin, artelin, and… (More)
  • figure I
  • figure 2
Is this relevant?
2001
2001
Solamargine, solasonine, ginsenosides and parishin-related compounds were investigated for their effects on mdr efflux pump of… (More)
Is this relevant?